Alnylam Pharmaceuticals Inc. (ALNY)

94.58 +1.63 (+1.754%)

IEX Real-Time Price

August 17, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 92.95

Price Open 93.18

Volume: 635,880

Avg Volume: 876,261

Market Cap: 9.52B

P/E Ratio -15.61

52 Wk Range 70.76-153.985



ALNY Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
100.26M
5.01M
7.96
5.00%

2018-07-13
100.11M
5.09M
8.21
5.09%

2018-06-29
100.11M
5.21M
7.89
5.20%

2018-06-15
100.12M
5.13M
7.72
5.13%




ALNY Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-04
Q1 2018
N/A
-1.48 (6)
0.00
0.00

2018-05-03
Q1 2018
AMC
-1.48 (6)
-1.41
0.07

2018-02-14
Q4 2017
N/A
-1.40 (8)
-1.48
-0.10

2018-02-08
Q4 2017
BTO
-1.38 (8)
-1.48
-0.10

News

The Battle For Best-In-Class In ATTR Has Begun (2018-08-16 11:52 SeekingAlpha)

With Alnylam (NASDAQ: ALNY ) securing FDA approval for Onpattro on Friday, August 10 th , 2018, the battle for "best-in-class" in transthyretin amyloidosis (ATTR) has officially begun. This approval gives Alnylam the early lead. Other competitors in the clinic include Ionis (NASDAQ:…

 


Statistics

Shares Outstanding: 100.67M

Top 15 Institution Percent: N/A

Price To Sales: 87.59

Price To Book: 5.87

Revenue: 55.02M

Gross Profit: N/A

Cash: 2.64B

Debt: N/A

Return On Assets: -35.36

Return On Equity: -41.54

Profit Margin: N/A

Price History

Beta: 2.46

50-day Moving Avg: 100.37

200-day Moving Avg: 114.41

YTD Change: -28.27

5-day Change: 3.99

1-month Change: -7.52

3-month Change: -6.95

6-month Change: -21.72

1-year Change: 17.81

Revenue Per Share: 1.00

Revenue Per Employee: 73458.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Alnylam Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.alnylam.com

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes.